- Home
- MCHPP vs ORMP Comparison
MCHPP vs ORMP Comparison
Compare MCHPP & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCHPP | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 170.3M |
| IPO Year | 2004 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MCHPP | ORMP |
|---|---|---|
| Price | $64.26 | $4.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.7K | ★ 170.7K |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | ★ 2300.00 | 412.50 |
| EPS | 0.37 | ★ 2.76 |
| Revenue | ★ $5,349,500,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $178.00 | ★ $1.74 |
| Revenue Growth | 34.38 | ★ 49.25 |
| 52 Week Low | $47.08 | $2.09 |
| 52 Week High | $88.00 | $5.19 |
Technical Indicators
Market Signals| Indicator | MCHPP | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.58 | 69.11 |
| Support Level | $61.71 | $3.91 |
| Resistance Level | $72.47 | $5.10 |
| Average True Range (ATR) | 2.07 | 0.19 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 11.57 | 83.33 |
Price Performance
Historical ComparisonAbout MCHPP Microchip Technology Incorporated
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.